Cargando…
Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia
The genetic polymorphisms of X-ray repair cross complementing group 1 (XRCC1), X-ray repair cross complementing group 3 (XRCC3), and xeroderma pigmentosum complementation group D (XPD) repair genes may lead to genetic instability and leukemogenesis. The purpose of the study was to evaluate the assoc...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052066/ https://www.ncbi.nlm.nih.gov/pubmed/24955348 http://dx.doi.org/10.1155/2014/213790 |
_version_ | 1782320180805763072 |
---|---|
author | Bănescu, Claudia Trifa, Adrian P. Demian, Smaranda Benedek Lazar, Erzsebeth Dima, Delia Duicu, Carmen Dobreanu, Minodora |
author_facet | Bănescu, Claudia Trifa, Adrian P. Demian, Smaranda Benedek Lazar, Erzsebeth Dima, Delia Duicu, Carmen Dobreanu, Minodora |
author_sort | Bănescu, Claudia |
collection | PubMed |
description | The genetic polymorphisms of X-ray repair cross complementing group 1 (XRCC1), X-ray repair cross complementing group 3 (XRCC3), and xeroderma pigmentosum complementation group D (XPD) repair genes may lead to genetic instability and leukemogenesis. The purpose of the study was to evaluate the association between XRCC1 Arg399Gln, Arg280His and Arg194Trp, XRCC3 Thr241Met, and XPD Lys751Gln polymorphisms and the risk of developing CML in Romanian patients. A total of 156 patients diagnosed with CML and 180 healthy controls were included in this study. We found no association between CML and XRCC1 or XRCC3 variant genotypes in any of the investigated cases. A significant difference was observed in the variant genotype frequencies of the XPD Lys751Gln polymorphism between the patients with CML and control group (for variant homozygous genotypes, OR = 2.37; 95% CI = 1.20–4.67; P value = 0.016 and for combined heterozygous and variant homozygous genotypes, OR = 1.72; 95% CI = 1.10–2.69; P value = 0.019). This was also observed when analyzing the variant 751Gln allele (OR = 1.54; 95% CI = 1.13–2.11; P value = 0.008). Our results suggest that the XPD Lys751Gln variant genotype increases the risk of CML. |
format | Online Article Text |
id | pubmed-4052066 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-40520662014-06-22 Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia Bănescu, Claudia Trifa, Adrian P. Demian, Smaranda Benedek Lazar, Erzsebeth Dima, Delia Duicu, Carmen Dobreanu, Minodora Biomed Res Int Research Article The genetic polymorphisms of X-ray repair cross complementing group 1 (XRCC1), X-ray repair cross complementing group 3 (XRCC3), and xeroderma pigmentosum complementation group D (XPD) repair genes may lead to genetic instability and leukemogenesis. The purpose of the study was to evaluate the association between XRCC1 Arg399Gln, Arg280His and Arg194Trp, XRCC3 Thr241Met, and XPD Lys751Gln polymorphisms and the risk of developing CML in Romanian patients. A total of 156 patients diagnosed with CML and 180 healthy controls were included in this study. We found no association between CML and XRCC1 or XRCC3 variant genotypes in any of the investigated cases. A significant difference was observed in the variant genotype frequencies of the XPD Lys751Gln polymorphism between the patients with CML and control group (for variant homozygous genotypes, OR = 2.37; 95% CI = 1.20–4.67; P value = 0.016 and for combined heterozygous and variant homozygous genotypes, OR = 1.72; 95% CI = 1.10–2.69; P value = 0.019). This was also observed when analyzing the variant 751Gln allele (OR = 1.54; 95% CI = 1.13–2.11; P value = 0.008). Our results suggest that the XPD Lys751Gln variant genotype increases the risk of CML. Hindawi Publishing Corporation 2014 2014-05-15 /pmc/articles/PMC4052066/ /pubmed/24955348 http://dx.doi.org/10.1155/2014/213790 Text en Copyright © 2014 Claudia Bănescu et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Bănescu, Claudia Trifa, Adrian P. Demian, Smaranda Benedek Lazar, Erzsebeth Dima, Delia Duicu, Carmen Dobreanu, Minodora Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia |
title | Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia |
title_full | Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia |
title_fullStr | Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia |
title_full_unstemmed | Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia |
title_short | Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia |
title_sort | polymorphism of xrcc1, xrcc3, and xpd genes and risk of chronic myeloid leukemia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052066/ https://www.ncbi.nlm.nih.gov/pubmed/24955348 http://dx.doi.org/10.1155/2014/213790 |
work_keys_str_mv | AT banescuclaudia polymorphismofxrcc1xrcc3andxpdgenesandriskofchronicmyeloidleukemia AT trifaadrianp polymorphismofxrcc1xrcc3andxpdgenesandriskofchronicmyeloidleukemia AT demiansmaranda polymorphismofxrcc1xrcc3andxpdgenesandriskofchronicmyeloidleukemia AT benedeklazarerzsebeth polymorphismofxrcc1xrcc3andxpdgenesandriskofchronicmyeloidleukemia AT dimadelia polymorphismofxrcc1xrcc3andxpdgenesandriskofchronicmyeloidleukemia AT duicucarmen polymorphismofxrcc1xrcc3andxpdgenesandriskofchronicmyeloidleukemia AT dobreanuminodora polymorphismofxrcc1xrcc3andxpdgenesandriskofchronicmyeloidleukemia |